top of page
  • IGF-1 LR3 x 10
  • IGF-1 LR3 x 10

IGF-1 LR3 x 10


PubChem SID 178101669

Molecular Formula C400H625N111O115S9

    • Conti E, Musumeci MB, Assenza GE, Quarta G, Autore C, Volpe M. Recombinant human insulin-like growth factor-1: a new cardiovascular disease treatment option? Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):258-71. doi: 10.2174/187152508785909456. PMID: 18855638.

    • De Leonibus C, Santoni A, Paradiso E, et al. Prenatal citalopram exposure induces hippocampal neurogenesis in the rat offspring. Neuropharmacology. 2015;95:355-363. doi: 10.1016/j.neuropharm.2015.04.002

    • Kolaczynski JW, Caro JF. Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits, and risks. Ann Intern Med. 1994 Jan 1;120(1):47-55. doi: 10.7326/0003-4819-120-1-199401010-00009. PMID: 8250456.

    • Nicholls AR, Holt RI. Growth Hormone and Insulin-Like Growth Factor-1. Front Horm Res. 2016;47:101-14. doi: 10.1159/000445173. Epub 2016 Jun 27. PMID: 27347885.

    • Wang N, Yang J, Gan G, Bao X, Wang L. Self-assembled insulin-like growth factor 1 peptides induce adipose stem cell differentiation to repair cartilage injury. Biomater Adv. 2022 Jun;137:212845. doi: 10.1016/j.bioadv.2022.212845. Epub 2022 May 12. PMID: 35929274.

    • Yuan S, Wan ZH, Cheng SL, Michaëlsson K, Larsson SC. Insulin-like Growth Factor-1, Bone Mineral Density, and Fracture: A Mendelian Randomization Study. J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1552-e1558. doi: 10.1210/clinem/dgaa963. PMID: 33462619; PMCID: PMC7993594.

    These studies cover various aspects of IGF-1 LR3, including its physiology and clinical implications, its potential therapeutic effects for diabetes, its potential to increase bone density, its potential to repair cartilage, and its role in increasing skeletal muscle mass.

bottom of page